Clinical Trials Browser

Phase 1/2 × UNKNOWN × Capecitabine × Clear all

NCT05016869 2022-08-18

Fruquintinib Plus Capecitabine as Maintenance Treatment of RAS / BRAF Wild-type Metastatic Colorectal Cancer

Phase 1/2 Unknown

Gastrointestinal

Colorectal Neoplasms

NCT04380103 2020-05-08

A Phase I/II Study of XELOXIRI and Bevacizumab as First-line Treatment in Metastatic Colorectal Cancer

Phase 1/2 Unknown

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms